First Clinical Implant of the VentrAssist Left Ventricular Assist System as Destination Therapy for End-Stage Heart Failure

The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2005-08, Vol.24 (8), p.1150-1154
Hauptverfasser:	Esmore, Donald S., Kaye, David, Salamonsen, Robert, Buckland, Mark, Rowland, Michael, Negri, Justin, Rowley, Yvonne, Woodard, John, Begg, John R., Ayre, Peter, Rosenfeldt, Franklin L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cardiology. Vascular system Cardiomyopathy, Dilated - diagnosis Cardiomyopathy, Dilated - surgery Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care Equipment Design Equipment Safety Follow-Up Studies Heart Heart Failure - diagnosis Heart Failure - surgery Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Ventricles - pathology Heart Ventricles - surgery Heart-Assist Devices Humans Intensive care medicine Male Medical sciences Risk Assessment Severity of Illness Index Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Time Factors Tomography, X-Ray Computed Treatment Outcome Ventricular Dysfunction, Left - diagnosis Ventricular Dysfunction, Left - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated cardiomyopathy. The implant and recovery were uneventful, and the patient survives at 17 months, is NYHA class II, and lives at home. This device shows promise in end-stage heart failure for permanent implantation and bridge to transplantation.
ISSN:	1053-2498 1557-3117
DOI:	10.1016/j.healun.2005.01.014